<DOC>
	<DOCNO>NCT00163202</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy atorvastatin 80 mg daily compare atorvastatin 10 mg daily reduce C-reactive protein level 26-week treatment period subject document coronary artery disease .</brief_summary>
	<brief_title>Comparative Atorvastatin Pleiotropic Effects</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Male female subject age majority &lt; 80 year Subjects LDLC &gt; 0.5 g/L ( 1.29 mmol/L ) &lt; 1.5 g/L ( 3.87 mmol/L ) , TG &lt; 4.00 g/L ( 4.56 mmol/L ) hsCRP &gt; 1.5 mg/L &lt; 15 mg/L Subjects document coronary artery disease . Female subject childbearing potential without contraception Subjects secondary hyperlipidemia Diabetic subject receive insulin Subjects contraindication statin therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>